United States Neurological Biomarkers Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     United States 
Neurological Biomarkers 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " U n i t e d  S t a t e s  N e u r o l o g i c a l  
B i o m a r k e r s  M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  
2 0 2 4 - 2 0 3 2 , "  t h e  U n i t e d  S t a t e s  n e u r o l o g i c a l  b i o m a r k e r s  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  
g r o w t h  r a t e  ( C A G R )  o f  4 . 2 0 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
T h e  U n i t e d  S t a t e s  n e u r o l o g i c a l  b i o m a r k e r s  m a r k e t  i s  w i t n e s s i n g  s u b s t a n t i a l  g r o w t h ,  p r i m a r i l y  
Report d r i v e n  b y  t h e  r i s i n g  p r e v a l e n c e  o f  n e u r o l o g i c a l  d i s o r d e r s ,  i n c l u d i n g  P a r k i n s o n ' s ,  A l z h e i m e r ' s ,  
a n d  m u l t i p l e  s c l e r o s i s .  I n  a d d i t i o n  t o  t h i s ,  t h e  i n c r e a s i n g  i n c i d e n c e  r a t e s  o f  t h e s e  d i s o r d e r s  
h a v e  i n t e n s i f i e d  t h e  n e e d  f o r  e a r l y  d i a g n o s i s  a n d  e f f e c t i v e  t r e a t m e n t ,  t h e r e b y  b o o s t i n g  t h e  
Highlight and d e m a n d  f o r  n e u r o l o g i c a l  b i o m a r k e r s .  T h e s e  b i o m a r k e r s  p l a y  a n  i m p o r t a n t  r o l e  i n  i d e n t i f y i n g  
t h e  b e g i n n i n g  a n d  p r o g r e s s i o n  o f  n e u r o l o g i c a l  d i s e a s e s ,  e n a b l i n g  h e a l t h c a r e  p r o f e s s i o n a l s  t o  
i m p l e m e n t  t i m e l y  a n d  t a r g e t e d  i n t e r v e n t i o n s .  
Description M o r e o v e r ,  a d v a n c e m e n t s  i n  b i o t e c h n o l o g y  a n d  g e n o m i c s  h a v e  l e d  t o  t h e  d i s c o v e r y  o f  
n u m e r o u s  n o v e l  b i o m a r k e r s ,  w h i c h  i s  c r e a t i n g  a  p o s i t i v e  o u t l o o k  f o r  t h e  m a r k e t .  B e s i d e s  t h i s ,  
t h e  i n t e g r a t i o n  o f  a r t i f i c i a l  i n t e l l i g e n c e  a n d  m a c h i n e  l e a r n i n g  i n  t h e  a n a l y s i s  o f  c o m p l e x  
n e u r o l o g i c a l  d a t a  i s  a l s o  p r o p e l l i n g  t h e  m a r k e t  f o r w a r d ,  a s  t h e s e  t e c h n o l o g i e s  i m p r o v e  t h e  
p r e c i s i o n  a n d  e f f i c i e n c y  o f  b i o m a r k e r  d i s c o v e r y .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - n e u r o l o g i c a l - b i o m a r k e r s - m a r k e t / r e q u e s t s a m p l e
Report Description
Uni ted Sta tes  Neurologica l  Biomarkers  Market  T rends :
Fur thermore ,  t he  inc reas ing  fund ing  and  research  in i t i a t i ves  a imed a t  unde rs tand ing  and  t rea t ing  neuro log ica l  
d iso rde rs  a re  augmen t ing  the  Un i ted  S ta tes  neuro log ica l  b iomarkers  marke t .  Add i t iona l ly ,  co l l abo ra t ive  e f fo r t s  
be tween  resea rch  ins t i t u t ions ,  pharmaceu t ica l  compan ies ,  and  government  agenc ies  wh ich  p rov ide  innova t ive  
approaches  to  b iomarker  deve lopment  and  va l ida t ion  a re  a l so  s t reng then ing  the  marke t  g rowth .  Moreover ,  the  
e leva t ing  awareness  o f  men ta l  hea l th  and  neuro log ica l  i l l nesses  has  resu l ted  in  fas te r  d iagnos is  and  t rea tmen t ,  
wh ich  i s  fue l i ng  the  demand fo r  re l i ab le  and  access ib le  b iomarke rs .  
Bes ides  th is ,  t he  emergence  o f  pe rsona l ized  med ic ine  in  neuro logy ,  whe re  t rea tment  and  d iagnos is  a re  ta i l o red  
to  ind iv idua l  gene t ic  p ro f i l es ,  i s  ano ther  key  fac to r  d r i v ing  the  g rowth  o f  t he  marke t .  Fu r the rmore ,  the  ongo ing  
research  and  deve lopment ,  as  we l l  as  the  inc reas ing  accep tance  o f  p rec is ion  med ic ine  a re  expec ted  to  d r i ve  the  
Un i ted  S ta tes  neu ro log ica l  b iomarkers  marke t  in  the  coming  years .
View Report  TOC,  F igures  and Tab les :  
h t tps : / /www. imarcgroup.com/uni ted-s ta tes-neurologica l -b iomarkers-market
Type Insights:
• Genomic Biomarkers
• Proteomic Biomarkers
• Metabolomic Biomarkers
• Imaging Biomarkers
• Others
Report 
Segmentation Application Insights:
• Alzheimer's Disease
• Parkinson's  Disease
• Mult iple Sclerosis
• Autism Spectrum Disorders
• Others
End Use Insights:
• Hospital  Laboratories
• Clinical  Diagnostic Centers
• Research Organizations
• Others
Report 
Regional Insights:
Segmentation • Northeast 
• Midwest 
• South
• West
How has the United States neurological biomarkers market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the United States 
neurological biomarkers market?
What is the breakup of the United States neurological 
biomarkers market on the basis of type?
Key 
What is the breakup of the United States neurological 
biomarkers market on the basis of application?
Questions 
What is the breakup of the United States neurological 
Answered in biomarkers market on the basis of end use?
the Report What are the various stages in the value chain of the United 
States neurological biomarkers market?
What are the key driving factors and challenges in the United 
States neurological biomarkers?
What is the structure of the United States neurological 
biomarkers market and who are the key players?
What is the degree of competition in the United States 
neurological biomarkers market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
Contents 4    U n i t e d  S t a t e s  N e u r o l o g i c a l  B i o m a r k e r s  M a r k e t  -  I n t r o d u c t i o n    4 . 1     O v e r v i e w
    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  N e u r o l o g i c a l  B i o m a r k e r s  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  N e u r o l o g i c a l  B i o m a r k e r s  M a r k e t  -  B r e a k u p  b y  T y p e
    6 . 1     G e n o m i c  B i o m a r k e r s
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     P r o t e o m i c  B i o m a r k e r s
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 3     M e t a b o l o m i c  B i o m a r k e r s
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 4     I m a g i n g  B i o m a r k e r s
        6 . 4 . 1  O v e r v i e w
        6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 5     O t h e r s
        6 . 5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
Table of 7    U n i t e d  S t a t e s  N e u r o l o g i c a l  B i o m a r k e r s  M a r k e t  -  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     A l z h e i m e r ' s  D i s e a s e
        7 . 1 . 1  O v e r v i e w
Contents         7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        7 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2     P a r k i n s o n ' s  D i s e a s e
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 3     M u l t i p l e  S c l e r o s i s
        7 . 3 . 1  O v e r v i e w
        7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 4     A u t i s m  S p e c t r u m  D i s o r d e r s
        7 . 4 . 1  O v e r v i e w
        7 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / u n i t e d - s t a t e s - n e u ro l o g i ca l - b i o m a r k
e r s - m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]